SCNI

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SCNI

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/14	20 : 26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/06/13	23 : 19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/06/13	23 : 16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/06/13	20 : 00	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/06/07	20 : 00	PR Newswire (US)	Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/29	03 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/25	05 : 01	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/17	02 : 49	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/16	06 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/16	05 : 01	PR Newswire (US)	Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/07	23 : 24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/05/06	22 : 21	PR Newswire (US)	Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/04/10	20 : 00	PR Newswire (US)	Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/04/09	06 : 15	AllPennyStocks.com	Biotech Rips Following Five-Year Master Service Agreement Release	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/04/08	20 : 00	PR Newswire (US)	Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/03/12	21 : 00	PR Newswire (US)	Scinai leadership to attend BIO-Europe Spring 2024	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/02/29	22 : 45	PR Newswire (US)	Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/02/13	21 : 00	PR Newswire (US)	Scinai Welcomes Liat Halpert as Head of Business Development and Sales	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/31	06 : 19	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/26	00 : 26	PR Newswire (US)	Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/25	04 : 33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/19	01 : 50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/12	21 : 32	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/09	22 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/05	06 : 37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/05	06 : 01	PR Newswire (US)	Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/04	20 : 15	PR Newswire (US)	Scinai Immunotherapeutics CEO Issues Letter to Shareholders	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/02	23 : 58	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/02	23 : 57	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd
2024/01/02	23 : 26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SCNI	Scinai Immunotherapeutics Ltd